Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Appropriate Antibiotic Use for Acute Otitis Media
Your Article Summary
See Latest ArticlesA survey of current practices of physicians who treat adductor spasmodic dysphonia in the U.S.
ENT Journal, 06/03/09
Chang CY et al. - Spasmodic dysphonia is a well-described entity that affects the laryngeal muscles. It is characterized by either strained/strangled voice breaks or breathy voice breaks. Other variants of spasmodic dysphonia include respiratory, tonic, and mixed types. Regardless of the specific type of spasmodic dysphonia, the mainstay of treatment is injection of botulinum toxin type A into the affected laryngeal muscles.
Related Articles
Comparing Health Locus of Control in Patients with Spasmodic Dysphonia, Functional Dysphonia and Nonlaryngeal Dystonia
Journal of Voice, 11/18/09
Relevance Score: 88%
Impact of Muscle Tension Dysphonia on Tonal Pitch Target Implementation in Vietnamese Female Teachers
Journal of Voice, 11/19/09
Relevance Score: 85%
Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study
Head & Face Medicine, 10/26/09
Relevance Score: 85%
Cricoid chondrosarcoma presenting as breathy dysphonia
ENT Journal, 10/16/09
Relevance Score: 85%
From dysphonia to dysphoria: Mokken scaling shows a strong, reliable hierarchy of voice symptoms in the Voice Symptom Scale questionnaire
Journal of Psychosomatic Research, 10/13/09
Relevance Score: 85%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 12/17/09
Single dose of preoperative analgesia with gabapentin (600 mg) is safe and effective in monitored anesthesia care for nasal surgery
European Archives of Oto-Rhino-Laryngology, 12/16/09
The shelf life of antimicrobial ear drops
The Laryngoscope, 12/15/09
Today in Larynx/Trachea/Airway...keeping you current
Receive free subspecialty "5-minute updates" via email
The ImmunoCAP Rapid Wheeze/Rhinitis Child test is useful in the initial allergy diagnosis of children with respiratory symptoms
Pediatric Allergy and Immunology, 12/18/09
Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence
Clinical Otolaryngology, 12/18/09
Can we perceptually rate alaryngeal voice? Developing the Sunderland Tracheoesophageal Voice Perceptual Scale
Clinical Otolaryngology, 12/18/09
Article Search
Sponsor